Press Room

AAPS 2023 PharmSci 360

Start
Sunday, October 22, 2023
End
Wednesday, October 25, 2023
Location: Orlando, USA
Booth Number: 2429

 

Visit Hovione’s booth at AAPS PharmSci 360 next October 22-23 in Orlando and meet our team of experts.

The AAPS PharmSci 360 Annual Meeting is organized by the American Association of Pharmaceutical Scientists (AAPS). The event provides a platform for pharmaceutical scientists from academia, industry, government, and other institutions worldwide to exchange knowledge and discuss the latest advancements in the field.

Schedule a meeting with our experts to learn how our end-to-end solutions in one site can support your projects.

Our experts traveling to Orlando will present the following posters:

 

HOVIONE POSTERS

 

Monday, October 23, 2023

Manufacturing and Analytical Characterization – Chemical
Impact of Alternative Lubricants on Tablet Parameters Approaching the Over-Lubrication Problems in Continuous Direct Compression Processes

  • 1:30 PM – 2:30 PM ET
  • Presenting: Nuno Branco, Ph.D.
  • Main Author: Tomas Santos, B.S.
     

Formulation and Delivery – Biomolecular
Hot and Cold Formulation of Biologics for the Optimization of Drying Technologies

  • 3:30 PM – 4:30 PM ET
  • Presenting: Paulo Lino, Ph.D.
  • Main Author: Susana Farinha, M.Sc.
     

Tuesday, October 24, 2023

Formulation and Delivery – Biomolecular
Analytical Characterization for Nucleic Acid Therapy: A Case Study

  • 12:30 PM – 1:30 PM ET
  • Main Author; Presenting: Rute Mota, M.Sc.
     

Formulation and Delivery – Chemical
Beyond Conventional Boundaries: New Excipients for ASD Formulation

  • 2:30 PM – 3:30 PM ET
  • Presenting; Main Author: Francisco Tavares, M.Sc.

 

Wednesday, October 25, 2023

Formulation and Delivery – Chemical
Dispersome® a Viable Alternative toward Enhanced Drug Load and Bioavailability

  • 9:30 AM – 10:30 AM ET
  • Presenting: Francisco Tavares, M.Sc.
  • Main Author: Maria Paisana, Ph.D.
     

Manufacturing and Analytical Characterization – Chemical
Challenges in Nitrosamine Determination for Pharmaceutical Products: An Analytical Perspective

  • 10:30 AM – 11:30 AM ET
  • Presenting; Main Author: Marco Galésio, Ph.D.
     

EXTRA PRESENTATION - Special Poster Collection

 

Tuesday, October 24, 2023 2:30 PM – 3:30 PM ET 

Location: Poster Forum #7; Exhibit Hall West A4-B3

 

Manufacturing and Analytical Characterization – Chemical
Impact of Alternative Lubricants on Tablet Parameters Approaching the Over-Lubrication Problems in Continuous Direct Compression Processes

  • Presenting: Nuno Branco, Ph.D.
  • Main Author: Tomas Santos, B.S.
     

Don’t miss the chance to speak with our team. Visit us at Booth #2429.
See you in Orlando.
 

 

Let’s discuss your project together.

schedule a meeting

 

 

 

Schedule a meeting with our experts.

 

Find more about AAPS PharmSci 360.

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025